Insider · CIK 0001579397
Shane William Charles Kovacs
Files at OLMA (Olema Pharmaceuticals, Inc.). First filing Dec 11, 2024, latest Dec 11, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OLMA: Olema Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | Olema Pharmaceuticals, Inc. | $317k 35,159 shares | -6% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +320,000 | $0.00 | $0 | 320,000 | Mar 3, 2025 |
| Dec 9, 2024 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Common Stock | +68,250 | $0.00 | $0 | 578,708 | Dec 11, 2024 |
| Dec 10, 2024 | OLMA Olema Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -16,803 | $9.37 | $157k | 561,905 | Dec 11, 2024 |
| Dec 11, 2024 | OLMA Olema Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -17,950 | $8.66 | $155k | 543,955 | Dec 11, 2024 |
| Dec 11, 2024 | OLMA Olema Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -406 | $9.39 | $3,812 | 543,549 | Dec 11, 2024 |
| Nov 15, 2024 | OLMA Olema Pharmaceuticals, Inc. | MOption exercise Common Stock | +25,000 | $7.02 | $176k | 510,458 | Nov 18, 2024 |
| Nov 15, 2024 | OLMA Olema Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 162,000 | Nov 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.